Chicago, IL – July, 2018. Chicago Inno is gearing up for its 4th annual Coolest Companies Competition that is taking place on August 22, 2018. The list of nominees comprises local startups and businesses that are characterized to have the best company culture. Featured on the tally of nominees is Tempus Labs, Inc., one of Chicago’s top ten technology firms that has been advancing cancer care through big data and analytics since 2015. Founded by Eric Lefkofsky, Tempus is one of few of the Chicago-based enterprises that has earned the title of unicorn for its valuation that surpassed $1 billion.
Chicago Inno has asked innovators to participate by contributing their opinions about why they think their business, including its perks, is the best and should be one of the ten winners that will be announced “Superlative Style” based on the characteristics that the nominators have sent in. A total of ten of the coolest companies will be announced on August 22nd, whereby five will be chosen from Readers’ Choice votes and five will be picked by the Chicago Inno team based on the superlatives categories.
Last year’s categories included superlatives such as best perks, best office, best social media presence (based on the number of times it was re-Tweeted), most giving and best wellness initiatives and programs.
Chicago Inno is a digital company that, since 2014, has been producing entertaining, authoritative stories and events about the city’s entrepreneurs, executives, startups, businesses, trends and topics that are making an impact on the present as well as the future of Chicago’s economy. Chicago Inno is a portal for the region’s startup and tech communities that publishes content about the city’s ecosystem via a daily newsletter, daily editorial, monthly events, directories, data and so much more.
According to the team at Tempus, an understanding of a patient’s clinical and molecular journey over time is crucial for modern precision medicine. Tempus is based on an interactive and analytical machine learning platform that compiles both clinical and molecular cancer patient data. The latter being based on the cancer patients’ genetic data that the company sequences in-house. Tempus has numerous collaborations with physicians and hospitals as well as with academic institutions and most of the nation’s top cancer centers. The company provides doctors with access to a variety of sequencing capabilities including DNA/RNA genomic sequencing services and analysis of molecular and therapeutic data. This enables them to make real-time, data-driven decisions so that each patient can benefit from those who came before.
About Eric Lefkofsky
In addition to Tempus, Eric Lefkofsky is a founding partner at Lightbank, a venture fund that focuses its investments on disruptive technologies; founding investor in Uptake Technologies, an analytics platform for the world’s largest industries; co-founder of Groupon, a global e-commerce marketplace; Mediaocean, an integrated media procurement technologies provider; Echo Global Logistics, a technology-enabled transportation and logistics outsourcing firm and InnerWorkings, whose focus is on providing managed print and promotional solutions globally.
Lefkofsky is a Trustee of the Lurie Children’s Hospital in Chicago, the Art Institute of Chicago, The Museum of Science and Industry and World Business Chicago. He also serves as the Board of Trustees’ Chairman of Chicago’s Steppenwolf Theatre Company. Eric and his wife Liz co-chair the Lefkofsky Family Foundation that supports high-impact initiatives that improve lives in the communities served. The two have also been part of the Giving Pledge since 2013. He is also part of Rise of the Rest, an organization that invests in startups across the nation. Lefkofsky currently holds an adjunct professorship at the University of Chicago’s Booth School of Business. He is the author of Accelerated Disruption: Understanding the True Speed of Innovation, in which he discusses several critical startup concepts as well as business development evolving at the speed of the next technological innovation.
For more information on Eric Lefkofsky, please visit lefkofsky.com, LinkedIn: ericlefkofsky, Twitter: @lefkofsky or Facebook: @eplefkofsky. For more information on Tempus, please visit tempus.com, Facebook: @TempusLabs and Twitter: @TempusLabs.